References
- Asghari, V., et al., 1995. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. Journal of neurochemistry, 65 (3), 1157–1165.
- Bailey, K.V. and Ferro-Luzzi, A., 1995. Use of body mass index of adults in assessing individual and community nutritional status. Bulletin of the World Health Organization, 73, 673–680.
- Benitez, B.A., et al., 2010. Exploration of genetic susceptibility factors for Parkinson's disease in a South American sample. Journal of genetics, 89 (2), 229–232.
- Bermudez-Silva, F.J., et al., 2010. The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning? Pharmacology, biochemistry, and behavior, 95 (4), 375–382.
- Cook, E.H. Jr., et al., 1995. Association of attention-deficit disorder and the dopamine transporter gene. The American journal of human genetics, 56, 993–998.
- Cuevas, A., Alvarez, V., and Olivos, C., 2009. The emerging obesity problem in Latin America. Expert review of cardiovascular therapy, 7 (3), 281–288.
- Davis, J.F., Choi, D.L., and Benoit, S.C., 2010. Insulin, leptin and reward. Trends in endocrinology and metabolism, 21 (2), 68–74.
- Faraone, S.V., et al., 2014. Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis. Molecular psychiatry, 19 (8), 880–889.
- Farooqi, I.S., 2011. Genetic, molecular and physiological insights into human obesity. European journal of clinical investigation, 41 (4), 451–455.
- Fonseca, D.J., et al., 2015. Lack of association of polymorphisms in six candidate genes in Colombian ADHD patients. Annals of neurosciences, 22 (4), 217–221.
- Fontana, C., et al., 2015. DRD4 and SLC6A3 gene polymorphisms are associated with food intake and nutritional status in children in early stages of development. The journal of nutritional biochemistry, 26 (12), 1607–1612.
- Forero, D.A., et al., 2014. Neuropsychiatric genetics in developing countries: current challenges. World journal of psychiatry, 4 (4), 69–71.
- Gabriela, M.L., et al., 2009. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients. Neuroscience letters, 451 (3), 257–260.
- German, C.L., et al., 2015. Regulation of the dopamine and vesicular monoamine transporters: pharmacological targets and implications for disease. Pharmacological reviews, 67 (4), 1005–1024.
- Gonzalez-Giraldo, Y., et al., 2015. No Association of BDNF, COMT, MAOA, SLC6A3, and SLC6A4 Genes and Depressive Symptoms in a Sample of Healthy Colombian Subjects. Depression research and treatment, 2015, 145483.
- Gonzalez-Giraldo, Y., Gonzalez-Reyes, R.E., and Forero, D.A., 2016. A functional variant in MIR137, a candidate gene for schizophrenia, affects Stroop test performance in young adults. Psychiatry research, 236, 202–205.
- Graff, M., et al., 2013. Genome-wide analysis of BMI in adolescents and young adults reveals additional insight into the effects of genetic loci over the life course. Human molecular genetics, 22, 3597–3607.
- Hebebrand, J., et al., 2013. Molecular genetic aspects of weight regulation. Deutsches arzteblatt international, 110 (19), 338–344.
- Herran, O.F., Patino, G.A., and Del Castillo, S.E., 2016. Dietary transition and excess weight in adults according to the Encuesta de la Situacion Nutricional en Colombia, 2010. Biomedica, 36, 109–120.
- Kanno, K., and Ishiura, S., 2011. Differential effects of the HESR/HEY transcription factor family on dopamine transporter reporter gene expression via variable number of tandem repeats. Journal of neuroscience research, 89 (4), 562–575.
- Kelly, T., et al., 2008. Global burden of obesity in 2005 and projections to 2030. International journal of obesity (2005), 32 (9), 1431–1437.
- Lam, D.D., et al., 2010. Brain serotonin system in the coordination of food intake and body weight. Pharmacology, biochemistry, and behavior, 97 (1), 84–91.
- Lim, S.S., et al., 2012. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380 (9859), 2224–2260.
- McGeary, J., 2009. The DRD4 exon 3 VNTR polymorphism and addiction-related phenotypes: a review. Pharmacology, biochemistry, and behavior, 93 (3), 222–229.
- McHugh, P.C. and Buckley, D.A., 2015. The structure and function of the dopamine transporter and its role in CNS diseases. Vitamins and hormones, 98, 339–369.
- Mitchell, R.J., et al., 2000. Distribution of the 3' VNTR polymorphism in the human dopamine transporter gene in world populations. Human biology, 72, 295–304.
- Mockus, I. and Trujillo, M. L., 2013. Obesidad y enfermedades asociadas. Bogota: Editorial Universidad Nacional de Colombia.
- Mueller, S.T. and Piper, B.J., 2014. The psychology experiment building language (PEBL) and PEBL test battery. Journal of neuroscience methods, 222, 250–259.
- Ng, M., et al., 2014. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 384 (9945), 766–781.
- Nikolova, Y.S., et al., 2011. Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity. Neuropsychopharmacology, 36 (9), 1940–1947.
- Oak, J.N., Oldenhof, J., and Van Tol, H.H., 2000. The dopamine D(4) receptor: one decade of research. European journal of pharmacology, 405 (1–3), 303–327.
- Ojeda, D.A., et al., 2014. A functional polymorphism in the promoter region of MAOA gene is associated with daytime sleepiness in healthy subjects. Journal of neurological science, 337, 176–179.
- Rosengren, A., et al., 2015. Psychosocial factors and obesity in 17 high-, middle- and low-income countries: the Prospective Urban Rural Epidemiologic study. International journal of obesity, 39, 1217–1223.
- Roussos, P., Giakoumaki, S.G., and Bitsios, P., 2009. Cognitive and emotional processing in high novelty seeking associated with the L-DRD4 genotype. Neuropsychologia, 47 (7), 1654–1659.
- Salatino-Oliveira, A., Rohde, L.A., and Hutz, M.H., 2017. The dopamine transporter role in psychiatric phenotypes. The American journal of medical genetics part B: neuropsychiatric genetics. [Epub ahead of print]. doi: 10.1002/ajmg.b.32578.
- Sikora, M., et al., 2013. Correlations between polymorphisms in genes coding elements of dopaminergic pathways and body mass index in overweight and obese women. Endokrynologia polska, 64, 101–107.
- Sole, X., et al., 2006. SNPStats: a web tool for the analysis of association studies. Bioinformatics, 22 (15), 1928–1929.
- Stanfill, A.G., et al., 2015. Neurogenetic and neuroimaging evidence for a conceptual model of dopaminergic contributions to obesity. Biological research for nursing, 17 (4), 413–421.
- Stevens, G.A., et al., 2012. National, regional, and global trends in adult overweight and obesity prevalences. Population Health Metrics, 10, 22.
- Swinburn, B.A., et al., 2011. The global obesity pandemic: shaped by global drivers and local environments. Lancet, 378 (9793), 804–814.
- Volkow, N.D., Wang, G.J., and Baler, R.D., 2011. Reward, dopamine and the control of food intake: implications for obesity. Trends in cognitive sciences, 15, 37–46.
- Volkow, N.D., et al., 2008. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philosophical transactions of the Royal Society of London. Series B, biological sciences, 363 (1507), 3191–3200.
- Volkow, N.D., et al., 2012. Food and drug reward: overlapping circuits in human obesity and addiction. Current topics in behavioral neurosciences, 11, 1–24.
- Zillikens, M.C., et al., 2017. Large meta-analysis of genome-wide association studies identifies five loci for lean body mass. Nature communications, 8 (1), 80.